Switch to
More onapp

How to use scorecard? Learn more

Orchid Pharma Ltd

ORCHPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,680 cr, stock is ranked 717
High RiskStock is 4.05x as volatile as Nifty
1,139.8519.90 (+1.78%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,680 cr, stock is ranked 717
High RiskStock is 4.05x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
62.01
PB RatioPB Ratio
8.25
Dividend YieldDiv. Yield
Sector PESector PE
Sector PBSector PB
Sector Div YldSctr Div Yld

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals.

Investor PresentationView older 

Aug 14, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

2021202220232024465.27627.03724.54850.23-116.55-1.9546.3292.17
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.56%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 4.78%

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnJun 28, 2024

Orchid Pharma Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India". | Download

Orchid Pharma Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India". | Download

Trading Window-XBRL 
Announced OnJun 27, 2024

Orchid Pharma Limited has informed the Exchange about Closure of Trading Window | Download

Orchid Pharma Limited has informed the Exchange about Closure of Trading Window | Download

Press Release 
Announced OnJun 6, 2024

Orchid Pharma Limited has informed the Exchange regarding a press release dated Jun 06, 2024, titled "Press Release- OrchidPharma receives DCGI approval for its first invented and made-in-IndiaAntibiotic Drug Combination of Cefepime and Enmetazobactam (NCE)". | Download

Orchid Pharma Limited has informed the Exchange regarding a press release dated Jun 06, 2024, titled "Press Release- OrchidPharma receives DCGI approval for its first invented and made-in-IndiaAntibiotic Drug Combination of Cefepime and Enmetazobactam (NCE)". | Download

See all events